SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

BRIEF-Actinogen Medical Ltd - U.S. FDA Grants ACW Rare Paediatric Disease Designation In FXS

· 02/04/2021 20:55
BRIEF-Actinogen Medical Ltd - U.S. FDA Grants ACW Rare Paediatric Disease Designation In FXS

- Actinogen Medical Ltd ACW.AX:

  • FDA GRANTS ACW RARE PAEDIATRIC DISEASE DESIGNATION IN FXS-ACW.AX

  • U.S. FDA GRANTED ACTINOGEN'S DRUG XANAMEM RARE PAEDIATRIC DISEASE DESIGNATION (RPDD) FOR TREATMENT OF FRAGILE X SYNDROME (FXS)

Source text for Eikon: ID:nASX9jbSNz

Further company coverage: ACW.AX


((Reuters.Briefs@thomsonreuters.com;))